<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00845962</url>
  </required_header>
  <id_info>
    <org_study_id>HD07.007</org_study_id>
    <secondary_id>118046</secondary_id>
    <nct_id>NCT00845962</nct_id>
  </id_info>
  <brief_title>A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia</brief_title>
  <official_title>Spinal Anesthesia With Bupivacaine or 2-chloroprocaine for Outpatient Elective Surgery: a Prospective, Randomized, Double-blind Comparison.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Montréal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacity and the readiness for discharge
      between two local anesthetics, bupivacaine and 2-chloroprocaine, used for spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many surgeries are performed under spinal anesthesia, including ambulatory surgeries. The
      standard agent used for spinal anesthesia is called bupivacaine. It's safe and effective, but
      has a major disadvantage. It has a long duration of action (up to 4 hours), witch can prolong
      unnecessarily the patient's stay in the recovery room and in hospital.

      Another local anesthetic available for spinal anesthesia is 2-chloroprocaine. It has been
      used since many years, but some serious cases of toxicity in the 80's led to an interruption
      of its utilization. Those cases have been proven to be associated with the preservative agent
      (bisulfite) that was added and to the low pH (&lt;3) of the drug.

      Since then, 2-chloroprocaine exists in a preservative-free formulation and has been used in
      thousands of patients worldwide, without any problem. The major advantage of 2-chloroprocaine
      is its shorter duration of action, permitting a faster recovery from anesthesia, and also
      permitting a faster discharge from hospital (in a context of ambulatory surgery)

      The purpose of this study is to compare the efficacity and the readiness for discharge (from
      the recovery room, and from hospital) between two local anesthetics, bupivacaine and
      2-chloroprocaine, used for spinal anesthesia in elective ambulatory surgeries.

      Patients, after consenting for the study, will be randomly assigned to the following groups:

        -  spinal anesthesia with chloroprocaine 2% 40 mg (2 mL)

        -  spinal anesthesia with bupivacaine 0,75% 7,5 mg (1 mL)

      An &quot;executant anesthesiologist&quot; will be responsible for performing the spinal anesthesia,
      with a 25 gauge Sprotte needle, at the level L2L3, L3L4 or L4L5. The &quot;responsible
      anesthesiologist&quot; will only take charge of the patient after the technique, so he stays
      double-blinded to the local anesthetic used. During surgery, if the patient feels pain, he
      may receive iv fentanyl, 25-100 µg at every 5 minutes.

      Measures will start immediately after the spinal block:

      Evaluation of the sensory block height (with ice):

        -  Every 3 minutes for 15 minutes (time to obtain a block a about T10)

        -  Every 5 minutes for 45 minutes (surgery)

        -  Every 10 minutes for 60 minutes, then every 15 minutes until the block regresses to S2
           (recovery room and ambulatory surgery unit)

      Evaluation of the motor block (using the Bromage scale):

        -  Every 3 minutes for 15 minutes

        -  At the beginning and at the end of the surgery

        -  After the surgery:every 10 minutes for 60 minutes, then every 15 minutes until the block
           regresses to S2 (recovery room and ambulatory surgery unit)

      (Bromage scale: full flexion of feet and knee = 0; able to move knee and feet, not hip = 1;
      able to move feet only = 2; unable to move feet or knee = 3)

      When the block will have regressed to S2, the patient will be asked to urinate. If he isn't
      able to urinate, this demand will be repeated every 15 minutes. (not applicable if the
      patient goes home with a urinary catheter)

      In the context of an ambulatory surgery, the patient will go home when he will meet the usual
      discharge criteria. All patients will receive a phone call from the research team the day
      after surgery, and 7 days later, to assess their satisfaction towards the analgesia and to
      inquire about potential complications of the spinal anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to obtain discharge criteria from recovery room</measure>
    <time_frame>within the first hours (1-2 h) after the surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to obtain discharge criteria from hospital</measure>
    <time_frame>within the same day of the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The amount of additional IV analgesia (fentanyl) administered during the intraoperative period</measure>
    <time_frame>total length of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The amount of iv analgesia (fentanyl and morphine) needed in the recovery room</measure>
    <time_frame>lenght of stay in the recovery room</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Chloroprocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>chloroprocaine</intervention_name>
    <description>spinal administration of chloroprocaine 2%, 40 mg (2 mL)</description>
    <arm_group_label>Chloroprocaine</arm_group_label>
    <other_name>Nesacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>spinal administration of bupivacaine 0,75% 7,5 mg (1 mL)</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged 18 years and older

          -  urologic elective ambulatory procedure. For example:cystoscopy,
             circumcision,transurethral bladder tumor resection, varicocele and hydrocele surgery

          -  gynecologic elective ambulatory procedure. For example: hysteroscopy, vulvar ou
             vaginal biopsy

          -  general surgery elective ambulatory procedure. For example:inguinal herniorraphy,
             short ano-rectal procedure

        Exclusion Criteria:

          -  INR &gt; 1,3

          -  platelet &lt; 75 000

          -  concomitant drugs: clopidogrel (last dose &lt; 7 days), iv heparin, low molecular weight
             heparin (last dose &lt; 24 hours)

          -  neurologic disease: spinal stenosis, symptomatic lumbar herniated disc, multiple
             sclerosis

          -  liquid restriction (cardiac or renal insufficiency)

          -  allergy or intolerance to chloroprocaine, bupivacaine or PABA

          -  atypical plasma cholinesterase or deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Denis Roy, MD</last_name>
    <role>Study Director</role>
    <affiliation>St-Luc hospital, CHUM, University of Montreal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luc Massicotte, MD</last_name>
    <role>Study Director</role>
    <affiliation>St-Luc Hospital, CHUM, University of Montreal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Andrée Lacasse, MD, resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>St-Luc hospital, CHUM, University of Montreal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St-Luc Hospital CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 3J4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg. 2004 Jan;98(1):75-80, table of contents.</citation>
    <PMID>14693590</PMID>
  </reference>
  <reference>
    <citation>Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg. 2004 Jan;98(1):81-8, table of contents.</citation>
    <PMID>14693591</PMID>
  </reference>
  <reference>
    <citation>Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg. 2004 Jan;98(1):89-94, table of contents.</citation>
    <PMID>14693593</PMID>
  </reference>
  <reference>
    <citation>Warren DT, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added dextrose. Anesth Analg. 2004 Jan;98(1):95-101, table of contents.</citation>
    <PMID>14693594</PMID>
  </reference>
  <reference>
    <citation>Kopacz DJ. Spinal 2-chloroprocaine: minimum effective dose. Reg Anesth Pain Med. 2005 Jan-Feb;30(1):36-42.</citation>
    <PMID>15690266</PMID>
  </reference>
  <reference>
    <citation>Davis BR, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added clonidine. Anesth Analg. 2005 Feb;100(2):559-65.</citation>
    <PMID>15673894</PMID>
  </reference>
  <reference>
    <citation>Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with small-dose bupivacaine in volunteers. Anesth Analg. 2005 Feb;100(2):566-72.</citation>
    <PMID>15673895</PMID>
  </reference>
  <reference>
    <citation>Gonter AF, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with procaine in volunteers. Anesth Analg. 2005 Feb;100(2):573-9.</citation>
    <PMID>15673896</PMID>
  </reference>
  <reference>
    <citation>Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg. 2005 Feb;100(2):553-8.</citation>
    <PMID>15673893</PMID>
  </reference>
  <reference>
    <citation>Casati A, Danelli G, Berti M, Fioro A, Fanelli A, Benassi C, Petronella G, Fanelli G. Intrathecal 2-chloroprocaine for lower limb outpatient surgery: a prospective, randomized, double-blind, clinical evaluation. Anesth Analg. 2006 Jul;103(1):234-8, table of contents.</citation>
    <PMID>16790659</PMID>
  </reference>
  <reference>
    <citation>Casati A, Fanelli G, Danelli G, Berti M, Ghisi D, Brivio M, Putzu M, Barbagallo A. Spinal anesthesia with lidocaine or preservative-free 2-chlorprocaine for outpatient knee arthroscopy: a prospective, randomized, double-blind comparison. Anesth Analg. 2007 Apr;104(4):959-64.</citation>
    <PMID>17377114</PMID>
  </reference>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2009</study_first_submitted>
  <study_first_submitted_qc>February 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2009</study_first_posted>
  <last_update_submitted>January 26, 2010</last_update_submitted>
  <last_update_submitted_qc>January 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jean-Denis Roy / MD Anesthesiologist</name_title>
    <organization>Centre hospitalier de l'université de Montréal (CHUM) / University of Montreal</organization>
  </responsible_party>
  <keyword>bupivacaine</keyword>
  <keyword>chloroprocaine</keyword>
  <keyword>spinal</keyword>
  <keyword>anesthesia</keyword>
  <keyword>elective surgery</keyword>
  <keyword>ambulatory surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

